Priority Date: 14.06.12 (US 201261659654P)

NOVEL ANTIBODY SPECIFIC FOR CLEC14A AND USES THEREOF

  • Application ID: EP13805033
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1974
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61, C07, and C12 is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 128 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 14.06.2012 - Priority Date (US 201261659654P)
  • 19.12.2013 - Publication A1 (WO2013187724)
  • 22.04.2015 - Publication A1 (EP2861623)